Amruta There
Apr 19, 2016
Mystic Pharmaceuticals Receives US Patent For Novel Nose To Brain Delivery Of Therapeutics To Treat Neurodegenerative Disorders
Mystic Pharmaceuticals Inc. has received a patent from the United States Patent Office for its “Dose Dispensing Containers” (US Patent 9,248,076 B2).